General Information of the Compound
| Compound ID |
CP0400066
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-fluoro-2-[4-methoxy-3-[2-(4-methylpiperidin-1-yl)ethoxy]phenyl]-4-methyl-3H-pyrrolo[3,4-b]indol-1-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H30FN3O3
|
||||||||||||||||||
| Molecular Weight |
451.542
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1OCCN1CCC(C)CC1)N1Cc2c(C1=O)c1cccc(F)c1n2C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H30FN3O3/c1-17-9-11-29(12-10-17)13-14-33-23-15-18(7-8-22(23)32-3)30-16-21-24(26(30)31)19-5-4-6-20(27)25(19)28(21)2/h4-8,15,17H,9-14,16H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
JNLFLPPNFADZFN-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C